Rubius Therapeutics
$0.057000
20
+$0.00+2.7% Friday 20:49
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
5.15M
P/E Ratio
0
Dividend Yield
-
Dividend
-
Earnings
8MayExpected
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Q1 2023
-0.61
-0.49
-0.36
-0.24
Expected EPS
-0.24
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-179.67MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Health Technology
Biotechnology
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatment of HPV-positive tumors; and RTX-T1D for treating type 1 diabetes. The company was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.
Show more...
CEO
Pablo Cagnoni
Employees
213
Country
United States
ISIN
US78116T1034
WKN
000A2JQ3H
Listings
0 Comments
Share your thoughts
FAQ
What is Rubius Therapeutics stock price today?▼
The current price of RUBY is $0.06 USD — it has increased by +2.7% in the past 24 hours. Watch Rubius Therapeutics stock price performance more closely on the chart.
What is Rubius Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTCM exchange Rubius Therapeutics stocks are traded under the ticker RUBY.
What is Rubius Therapeutics market cap?▼
Today Rubius Therapeutics has the market capitalization of 5.15M
What is Rubius Therapeutics revenue for the last year?▼
Rubius Therapeutics revenue for the last year amounts to 0 USD.
What is Rubius Therapeutics net income for the last year?▼
RUBY net income for the last year is -179.67M USD.
How many employees does Rubius Therapeutics have?▼
As of July 18, 2026, the company has 213 employees.
In which sector is Rubius Therapeutics located?▼
Rubius Therapeutics operates in the Technology sector.
When did Rubius Therapeutics complete a stock split?▼
Rubius Therapeutics has not had any recent stock splits.
Where is Rubius Therapeutics headquartered?▼
Rubius Therapeutics is headquartered in Cambridge, United States.